214 related articles for article (PubMed ID: 30026231)
1. Lysophosphatidic acid produced by autotaxin acts as an allosteric modulator of its catalytic efficiency.
Salgado-Polo F; Fish A; Matsoukas MT; Heidebrecht T; Keune WJ; Perrakis A
J Biol Chem; 2018 Sep; 293(37):14312-14327. PubMed ID: 30026231
[TBL] [Abstract][Full Text] [Related]
2. Kinetic analysis of autotaxin reveals substrate-specific catalytic pathways and a mechanism for lysophosphatidic acid distribution.
Saunders LP; Cao W; Chang WC; Albright RA; Braddock DT; De La Cruz EM
J Biol Chem; 2011 Aug; 286(34):30130-41. PubMed ID: 21719699
[TBL] [Abstract][Full Text] [Related]
3. The Role of Autotaxin and LPA Signaling in Embryonic Development, Pathophysiology and Cancer.
Magkrioti C; Kaffe E; Aidinis V
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176032
[TBL] [Abstract][Full Text] [Related]
4. Autotaxin/Lysophosphatidic Acid Axis: From Bone Biology to Bone Disorders.
Alioli C; Demesmay L; Peyruchaud O; Machuca-Gayet I
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408784
[TBL] [Abstract][Full Text] [Related]
5. Structure-Based Design of a Novel Class of Autotaxin Inhibitors Based on Endogenous Allosteric Modulators.
Clark JM; Salgado-Polo F; Macdonald SJF; Barrett TN; Perrakis A; Jamieson C
J Med Chem; 2022 Apr; 65(8):6338-6351. PubMed ID: 35440138
[TBL] [Abstract][Full Text] [Related]
6. Recent research advances in ATX inhibitors: An overview of primary literature.
Zhang C; Liu Y; Zhou Q; Fan H; Liu X; Hu J
Bioorg Med Chem; 2023 Jul; 90():117374. PubMed ID: 37354726
[TBL] [Abstract][Full Text] [Related]
7. Autotaxin facilitates selective LPA receptor signaling.
Salgado-Polo F; Borza R; Matsoukas MT; Marsais F; Jagerschmidt C; Waeckel L; Moolenaar WH; Ford P; Heckmann B; Perrakis A
Cell Chem Biol; 2023 Jan; 30(1):69-84.e14. PubMed ID: 36640760
[TBL] [Abstract][Full Text] [Related]
8. Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity.
Ferry G; Tellier E; Try A; Grés S; Naime I; Simon MF; Rodriguez M; Boucher J; Tack I; Gesta S; Chomarat P; Dieu M; Raes M; Galizzi JP; Valet P; Boutin JA; Saulnier-Blache JS
J Biol Chem; 2003 May; 278(20):18162-9. PubMed ID: 12642576
[TBL] [Abstract][Full Text] [Related]
9. Identification of two novel chemical classes of Autotaxin (ATX) inhibitors using Enalos Asclepios KNIME nodes.
Stylianaki EA; Mouchlis VD; Magkrioti C; Papavasileiou KD; Afantitis A; Matralis AN; Aidinis V
Bioorg Med Chem Lett; 2024 May; 103():129690. PubMed ID: 38447786
[TBL] [Abstract][Full Text] [Related]
10. Fluorogenic phospholipid substrate to detect lysophospholipase D/autotaxin activity.
Ferguson CG; Bigman CS; Richardson RD; van Meeteren LA; Moolenaar WH; Prestwich GD
Org Lett; 2006 May; 8(10):2023-6. PubMed ID: 16671772
[TBL] [Abstract][Full Text] [Related]
11. Roles of Autotaxin/Autotaxin-Lysophosphatidic Acid Axis in the Initiation and Progression of Liver Cancer.
She S; Zhang Q; Shi J; Yang F; Dai K
Front Oncol; 2022; 12():922945. PubMed ID: 35769713
[TBL] [Abstract][Full Text] [Related]
12. Type I Interferons Function as Autocrine and Paracrine Factors to Induce Autotaxin in Response to TLR Activation.
Song J; Guan M; Zhao Z; Zhang J
PLoS One; 2015; 10(8):e0136629. PubMed ID: 26313906
[TBL] [Abstract][Full Text] [Related]
13. Crystallization and preliminary X-ray crystallographic analysis of human autotaxin.
Inoue K; Tanaka N; Haga A; Yamasaki K; Umeda T; Kusakabe Y; Sakamoto Y; Nonaka T; Deyashiki Y; Nakamura KT
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Apr; 67(Pt 4):450-3. PubMed ID: 21505238
[TBL] [Abstract][Full Text] [Related]
14. Autotaxin Has a Negative Role in Systemic Inflammation.
Nikitopoulou I; Katsifa A; Kanellopoulou P; Jahaj E; Vassiliou AG; Mastora Z; Dimopoulou I; Orfanos SE; Aidinis V; Kotanidou A
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887265
[TBL] [Abstract][Full Text] [Related]
15. Autotaxin in Breast Cancer: Role, Epigenetic Regulation and Clinical Implications.
Drosouni A; Panagopoulou M; Aidinis V; Chatzaki E
Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358855
[TBL] [Abstract][Full Text] [Related]
16. Linking the Autotaxin-LPA Axis to Medicinal Cannabis and the Endocannabinoid System.
Eymery MC; Boumendjel A; McCarthy AA; Hausmann J
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542186
[TBL] [Abstract][Full Text] [Related]
17. Autotaxin and Lysophosphatidic Acid Signalling: the Pleiotropic Regulatory Network in Cancer.
Vít O; Petrák J
Folia Biol (Praha); 2023; 69(5-6):149-162. PubMed ID: 38583176
[TBL] [Abstract][Full Text] [Related]
18. LPA and Autotaxin: Potential Drug Targets in Asthma?
Georas SN
Cell Biochem Biophys; 2021 Sep; 79(3):445-448. PubMed ID: 34331220
[TBL] [Abstract][Full Text] [Related]
19. Autotaxin signaling facilitates β cell dedifferentiation and dysfunction induced by Sirtuin 3 deficiency.
Cao H; Chung ACK; Ming X; Mao D; Lee HM; Cao X; Rutter GA; Chan JCN; Tian XY; Kong APS
Mol Metab; 2022 Jun; 60():101493. PubMed ID: 35398277
[TBL] [Abstract][Full Text] [Related]
20. Single-cell transcriptome dynamics of the autotaxin-lysophosphatidic acid axis during muscle regeneration reveal proliferative effects in mesenchymal fibro-adipogenic progenitors.
Contreras O; Harvey RP
Front Cell Dev Biol; 2023; 11():1017660. PubMed ID: 36910157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
